Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 15/20 | 0.45 |
| ▸ | GSK3A | P49840 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 6/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.33 |
| ▸ | CCR6 | P51684 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13743120 | 0.85 | MGLL (0.35) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL29017 | 0.81 | MGLL (0.45) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL4841161 | 0.80 | GSK3A (0.31) | MGLLGSK3AGSK3B | |
| SCHEMBL13968985 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL331187 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL969752 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL13742892 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL19546122 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL22289873 | 0.77 | MGLL (0.41) | MGLLGSK3AGSK3BALDH1A1LMNA | |
| SCHEMBL9634966 | 0.77 | ALDH1A1 (0.37) | MGLLGSK3AGSK3BALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1725 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260126453-A1 | Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof | THE BINDING SITE GROUP LTD (GB) | 2026-05-07 | — | — | US | claimed |
| US-12560608-B2 | Detection of molecular associations | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2026-02-24 | — | — | US | claimed |
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 2026-02-12 | — | — | US | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| WO-2025235971-A1 | METHODS FOR DETECTING DNA SEQUENCE VARIATION IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-11-13 | — | — | WO | claimed |
| US-12461108-B2 | Mass spectrometry kit including a cross-linked antibody or fragment thereof | THE BINDING SITE GROUP LIMITED (GB) | 2025-11-04 | — | — | US | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-4615969-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | The Johns Hopkins University (US) | 2025-09-17 | — | — | EP | claimed |
| US-20250179125-A1 | Alpha-sheet Polypeptides and Their Use | UNIVERSITY OF WASHINGTON | 2025-06-05 | — | — | US | claimed |
| EP-4541374-A2 | DEFINED MULTI-CONJUGATE OLIGONUCLEOTIDES | Mpeg LA, L.l.c. (US) | 2025-04-23 | — | — | EP | claimed |
| EP-1549350-B1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DE GMBH (DE) | 2008-09-24 | — | — | EP | claimed |
| US-20080181965-A1 | Loaded latex optical molecular imaging probes | QUANTUM MEDICAL HOLDINGS, LLC | 2008-07-31 | — | — | US | claimed |
| US-20070254311-A1 | Covalent modification and conjugation of luciferase | CARDIOGENICS INC. (CA) | 2007-11-01 | — | — | US | claimed |
| WO-2006094826-A2 | METHOD FOR COUPLING ENZYMATICALLY ACTIVATED GLYCOCONJUGATES TO A HYDROXYALKYL STARCH | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-09-14 | — | — | WO | claimed |
| US-20060165677-A1 | DELETION FORMS OF IgE-DEPENDENT HISTAMINE RELEASING FACTOR HAVING HISTAMINE RELEASING ACTIVITY, HRF-BINDING PEPTIDES AND THE USES THEREOF | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2006-07-27 | — | — | US | claimed |
| EP-1683866-A2 | Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof | Ewha University-Industry Collaboration Foundation (KR) | 2006-07-26 | — | — | EP | claimed |
| US-20060100163-A1 | Pharmaceutically active oligosaccharide conjugates | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| US-20050176642-A1 | Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 | UNIVERSITY OF MARYLAND, BALTIMORE | 2005-08-11 | — | — | US | claimed |
| EP-1549350-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | Fresenius Kabi Deutschland GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| WO-2004032971-A1 | PHARMACEUTICALLY ACTIVE OLIGOSACCHARIDE CONJUGATES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2004-04-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080181965-A1 | Loaded latex optical molecular imaging probes | MLX, LOXL1, EPX | MGLL 38/4885GSK3A 4395/4885GSK3B 4307/4885 |
| US-20260126453-A1 | Mass Spectrometry Kit Including a Cross-linked Antibody or Fragment Thereof | IGLV6-57, IGSF11, FCGR3B | MGLL 3531/4885GSK3A 4449/4885GSK3B 4491/4885 |
| US-20260043066-A1 | COMPOSITIONS AND METHODS RELATED TO KETHOXAL DERIVATIVES | RNMT, SMCHD1, PKLR | MGLL 1183/4885GSK3A 2413/4885GSK3B 2327/4885 |
| US-20050176642-A1 | Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 | CD4, CD40LG, NECTIN4 | MGLL 2728/4885GSK3A 1869/4885GSK3B 1730/4885 |
| US-12560608-B2 | Detection of molecular associations | APP, SPPL2A, SPPL2B | MGLL 4623/4885GSK3A 4332/4885GSK3B 4338/4885 |
| US-20250179125-A1 | Alpha-sheet Polypeptides and Their Use | IAPP, APP, PRNP | MGLL 2722/4885GSK3A 1231/4885GSK3B 1476/4885 |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | MGLL 4186/4885GSK3A 4392/4885GSK3B 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.